Atlas Trials

A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma

Clinical trial NCT01353482 · WITHDRAWN

Trial details

NCT number
NCT01353482
Sponsor
University College, London
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Pleural Mesothelioma
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.